Results 1 to 10 of about 235,819 (313)
Some of the next articles are maybe not open access.
Nihon rinsho. Japanese journal of clinical medicine, 1996
Y, Wanaka, N, Nakamura, Y, Ueno
openaire +1 more source
Y, Wanaka, N, Nakamura, Y, Ueno
openaire +1 more source
Factors associated with angiotensin II stimulating vs. inhibiting antihypertensive drug use in older adults [PDF]
BMC GeriatricsBackground Limited understanding exists regarding factors associated with use of angiotensin II–inhibiting drugs (AIDs) vs. angiotensin II–stimulating drugs (ASDs), antihypertensive treatments increasingly studied for potential neuroprotective effects ...
Nistha Shrestha +6 more
doaj +2 more sources
Angiotensin II and Cardiovascular Disease: Balancing Pathogenic and Protective Pathways
Current Issues in Molecular BiologyThe renin-angiotensin-aldosterone system (RAAS) is a hormone system that controls blood pressure and fluid and electrolyte balance. Angiotensin II, a key effector, is produced from angiotensin I by angiotensin-converting enzyme (ACE) and exerts its ...
Ulvi Bayraktutan
doaj +3 more sources
Upregulation of NADH/NADPH oxidase 4 by angiotensin II induces podocyte apoptosis [PDF]
Kidney Research and Clinical Practice, 2023 Background Angiotensin II induces glomerular and podocyte injury via systemic and local vasoconstrictive or non-hemodynamic effects including oxidative stress. The release of reactive oxygen species (ROS) from podocytes may participate in the development
Tae-Sun Ha +3 more
doaj +1 more source
Open Access Emergency Medicine, 2010 T S Mohamed Saleem1, K Bharani1, K Gauthaman21Department of Pharmacology, Annamacharya College of Pharmacy, Rajampet-516126, Kadapa Dist, Andhra Pradesh, India; 2Department of Drug Technology, Higher Institute of Medical Technology, Derna, LibyaAbstract:
T S Mohamed Saleem +2 more
doaj +1 more source